Please assess the completion status of the following clinical trial:

Trial Title: A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Psychotic patients with schizophrenia who require rapid intervention~* experiencing symptoms of a psychotic disorder~* capable of choosing to be treated~Exclusion Criteria:~* Patients with a known hypersensitivity to the study drugs~* have participated in an investigational drug trial within 30 days of study initiation~* known to be unresponsive to treatment with risperidone or the comparator drug~* known to have benzodiazepine dependence (addiction to this class of anti-anxiety drugs)

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).